Cargando…

Risk of SARS-CoV-2 Breakthrough Infection in Vaccinated Cancer Patients: A Retrospective Cohort Study

Although messenger RNA (mRNA) vaccines have established efficacy for prevention of severe SARS-CoV2 infection in the general population, their effectiveness in patients with malignancy, especially those on anti-neoplastic therapies, remains an area of open research. In order to better understand the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rooney, Anthony, Bivona, Cory, Liu, Ben, Streeter, David, Gong, Han, Khan, Qamar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9123710/ https://www.ncbi.nlm.nih.gov/pubmed/35597960 http://dx.doi.org/10.1186/s13045-022-01290-8

Ejemplares similares

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
por: Wijtvliet, Veerle, et al.
Publicado: (2021)

Antibody titers and breakthrough infections with Omicron SARS-CoV-2
por: Dimeglio, Chloé, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough infection following a previous infection in a healthcare worker
por: Gupta, Aayush, et al.
Publicado: (2022)

Genomic survey of SARS-CoV-2 vaccine breakthrough infections in healthcare workers from Kerala, India
por: Philomina J, Beena, et al.
Publicado: (2021)

Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
por: Gao, Bo, et al.
Publicado: (2023)

Vaccine‐breakthrough infection by the SARS‐CoV‐2 omicron variant elicits broadly cross‐reactive immune responses
por: Zhou, Runhong, et al.
Publicado: (2022)

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)
por: Schildgen, Verena, et al.
Publicado: (2022)

Breakthrough infection shapes humoral immunity against SARS-CoV-2 Omicron Variant
por: Zhang, Yuwei, et al.
Publicado: (2023)

Impact of time elapsed since full vaccination on SARS-CoV-2 RNA load in Delta-variant breakthrough COVID-19
por: de Michelena, Paula, et al.
Publicado: (2022)

A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional
por: Pandit, Priyanka, et al.
Publicado: (2022)

Virovore: A Breakthrough in Virology
por: Sultana, Qamar, et al.
Publicado: (2023)

Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern
por: Yadav, Pragya D., et al.
Publicado: (2022)

Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
por: Mizoue, Tetsuya, et al.
Publicado: (2022)

Longitudinal analysis of the evolution of cellular immunity to SARS-CoV-2 induced by infection and vaccination
por: Vasileiou, Spyridoula, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Risks of SARS-CoV-2 Breakthrough Infection and Hospitalization in Fully Vaccinated Patients With Multiple Myeloma
por: Wang, Lindsey, et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infections in vaccinated individuals requiring ventilatory support for severe acute respiratory failure
por: Finazzi, Stefano, et al.
Publicado: (2023)

Emerging vaccine-breakthrough SARS-CoV-2 variants
por: Wang, Rui, et al.
Publicado: (2021)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine
por: Mizrahi, Barak, et al.
Publicado: (2021)

Central diabetes insipidus revealing a hypophysitis induced by SARS-CoV-2 vaccine()
por: Ach, Taieb, et al.
Publicado: (2022)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Predictors of death in COVID-19 vaccine breakthrough infections in Brazil
por: Estofolete, Cassia Fernanda, et al.
Publicado: (2022)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients
por: Capecchi, Marco, et al.
Publicado: (2023)

SARS-CoV-2 Breakthrough Infections after introduction of 4 COVID-19 Vaccines, South Korea, 2021
por: Yi, Seonju, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough reinfection in a health-care worker of Iraq: A case report
por: Hasan, Dlshad Abdullah, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9rf0cg88va84b2sp39f2ej8558